Advertisement

Topics

BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

01:38 EDT 1 Oct 2018 | BioPortfolio Report Blog

BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report


Summary


BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


BioMarin Pharmaceutical Inc. BioMarin or 'the company', a biotechnology company, develops and commercializes biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as Kyndrisa drisapersen, Duchenne muscular dystrophy DMD, phenylketonuria PKU, achondroplasia, late infantile neuronal ceroid lipofuscinosis CLN2 and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates in the US, Europe, Latin America, and other regions of the world. BioMarin is headquartered in San Rafael, California.


Scope


Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis

An indepth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments

Intelligence on BioMarin Pharmaceutical Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on BioMarin Pharmaceutical Inc.'s business structure, strategy and prospects.

Original Article: BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "BioMarin Pharmaceutical Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...